XML 87 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Income Statement      
Net sales $ 1,254,456 $ 1,169,747 $ 1,087,431
Cost of sales 430,432 419,938 371,869
Gross profit 824,024 749,809 715,562
Operating expenses:      
Research and development 122,476 130,636 126,040
Sales and marketing 343,549 307,332 267,484
General and administrative, restructuring, integration and other 152,068 185,507 110,009
Acquisition-related intangible amortization 36,117 26,746 23,492
Total operating expenses 654,210 650,221 527,025
Income from operations 169,814 99,588 188,537
Other income (expense):      
Interest income 2,382 6,128 4,457
Interest expense (23,452) (25,358) (27,815)
Other (expense) income, net (3,591) 15,854 7,942
Total other expense (24,661) (3,376) (15,416)
Income before provision for income taxes 145,153 96,212 173,121
Provision for income taxes 15,616 1,263 28,810
Net income 129,537 94,949 144,311
Net income (loss) attributable to noncontrolling interest 31 (1,089) 0
Net income attributable to the owners of QIAGEN N.V. $ 129,506 $ 96,038 $ 144,311
Basic earnings per common share attributable to the owners of QIAGEN N.V. $ 0.55 $ 0.41 $ 0.62
Diluted earnings per common share attributable to the owners of QIAGEN N.V. $ 0.54 $ 0.40 $ 0.60
Weighted-average common shares outstanding (in thousands)      
Basic (in shares) 235,582 233,850 232,635
Diluted (in shares) 240,746 239,064 240,483